minibanner
Research on Cancers in Women — NCI Office of Women's Health


Site Menu:

Quick Links

AIDS-Associated Malignancies

AIDS-Related Cancer Information for Patients and Health Professionals



Overview

While the number of deaths per year in the United States due to AIDS (acquired immunodeficiency syndrome) has decreased in the era of highly active antiretroviral therapy (HAART), the numbers of persons living with the disease has increased. The AIDS-defining malignancies are non-Hodgkin's lymphoma (NHL), cervical cancer, anal cancer, and Kaposi's sarcoma (KS). Although KS is extremely rare among women, NHL currently ranks fifth in overall female cancer incidence and seventh in mortality. In addition, there is an increased incidence of NHL in women from the pre-HAART to HAART period. The risk of cervical neoplasia is five times higher in women with HIV (human immunodeficiency virus) infection than in HIV negative women, due to a higher prevalence and persistence of oncogenic HPV (human papillomavirus) infection. The prognosis for cervical cancer is also poorer for HIV positive than for HIV negative women. Women infected with HIV and HPV also have a 6.8 fold greater risk of invasive anal cancer than HIV negative, HPV positive women.

Globally, almost half of the adults living with HIV and AIDS today are women. There has been a steady increase in the number of women and girls infected with HIV over the last two years, most dramatically in sub-Saharan Africa where women and girls make up almost 60% of adults living with HIV.

Back to Top

Statistics

Source: Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Vol. 17. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006:1–46. Also available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/.

For additional information on HIV/AIDS infection in women in the U.S., see the CDC Fact Sheet: HIV/AIDS among Women.

Back to Top

NCI Research on AIDS-Associated Malignancies

Information about NCI-funded grants, clinical trials, and other programs and initiatives with components that primarily target AIDS-associated malignancies.

Back to Top

Last Updated:  June 2007